Engineered Receptor-Biased IL-2–Drug Immunoconjugates Selectively Expand Tregs and Suppress Effector Cells for Autoimmune Therapy
Fields of Study & Subjects
T-cell and B-cell Immunology
Psoriasis: Treatment and Pathogenesis
Immunotoxicology and immune responses
Publication details
- Journal / source
- SSRN Electronic Journal
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint